Organization
Shanghai Pharma Biotherapeutics
2 clinical trials
Clinical trial
A Phase 2 Multicenter, Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic LiposarcomasStatus: Recruiting, Estimated PCD: 2025-03-01
Clinical trial
A Double-Blind, Placebo-Controlled Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of SPH3127 in Patients With Mild-to-Moderate Ulcerative ColitisStatus: Recruiting, Estimated PCD: 2025-12-01